Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.
Journal
Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
received:
20
01
2021
accepted:
07
05
2021
pubmed:
15
5
2021
medline:
20
4
2022
entrez:
14
5
2021
Statut:
ppublish
Résumé
Deprescribing is the systematic process of discontinuing drugs when harms outweigh the benefits. We conducted semistructured telephone interviews with 22 general practitioners (GPs) who had prescribed or deprescribed opioids in patients with chronic noncancer pain within the past 6 months to investigate the barriers and facilitators to deprescribing opioid analgesics in patients with chronic noncancer pain. We also explored GPs' perspectives on the available resources to assist them with opioid deprescribing. Interviews were audio-recorded, transcribed verbatim, and then coded using an iterative process until data saturation reached. The thematic analysis process identified themes, first as concepts, and then refined to overarching themes after the merging of similar subthemes. Themes exploring barriers to deprescribing highlighted the difficulties GPs face while considering patient factors and varying prescribing practices within the confines of the health system. Patient motivation and doctor-patient rapport were central factors to facilitate deprescribing and GPs considered the most important deprescribing resource to be a multidisciplinary network of clinicians to support themselves and their patients. Therefore, although GPs emphasised the importance of deprescribing opioid analgesics, they also expressed many barriers relating to managing complex pain conditions, patient factors, and varying prescribing practices between clinicians. Some of these barriers could be mitigated by GPs having time and resources to educate and build rapport with their patients. This suggests the need for further development of multimodal resources and improved support through the public health system to enable GPs to prioritise patient-centred care.
Identifiants
pubmed: 33990105
doi: 10.1097/j.pain.0000000000002340
pii: 00006396-202204000-00022
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e518-e526Informations de copyright
Copyright © 2021 International Association for the Study of Pain.
Références
Ailabouni NJ, Nishtala PS, Mangin D, Tordoff J. Challenges and enablers of deprescribing: a general practitioner perspective. PLoS One 2016;11:4.
Al Rasheed MM, Alhawassi TM, Alanazi A, Aloudah N, Khurshid F, Alsultan M. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study. Clin Interv Aging 2018;13:1401–8.
Australian Atlas of Healthcare Variation. Chapter 5.1. Opioid medicines dispensing. Available at: https://www.safetyandquality.gov.au/sites/default/files/migrated/SAQ201_06_Chapter5_v12_FILM_tagged_merged_5-1.pdf . Accessed May 28, 2020.
Australian Institute of Health and Welfare. Australia's health 2018. Canberra: AIHW, 2018.
Australian Institute of Health and Welfare. Rural & remote health. Cat. no. PHE 255. Canberra: AIHW, 2019. Available at: https://www.aihw.gov.au/reports/rural-remote-australians/rural-remote-health . Accessed May 28, 2020.
Blyth FM, March L, Brnabic A, Jorm L, Williamson M, Cousins M. Chronic pain in Australia: a prevalence study. PAIN 2001;89:127–34.
Braun V, Clarke V. Successful qualitative research: A practical guide for beginners. London: SAGE, 2013.
Busse JW, Wang L, Kamaleldin M, Craigie S, Riva J, Montoya L, Mulla S, Lopes L, Vogel N, Chen E, Kirmayr K, Oliveira K, Olivieri L, Kaushal A, Chaparro L, Oyberman I, Agarwal A, Couban R, Tsoi L, Lam T, Vanvik P, Hsu S, Bala M, Schandelmaier S, Scheidecker A, Ebrahim S, Ashoorion V, Rehman Y, Hong P, Ross S, Johnston B, Kunz R, Sun X, Buckley N, Sessler D, Guyatt G. Opioids for chronic non-cancer pain. A systematic review and meta analysis. JAMA 2018;320:2448–60.
Chou R, Turner JA, Devine EB, Hansen R, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med 2015;162:276–86.
Click IA, Basden JA, Bohannon JM, Anderson H, Tudiver F. Opioid prescribing in rural family practices: a qualitative study. Subst Use Misuse 2018;53:533–40.
Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall B, Bruneau J, Altice F, Henderson G, Rahimi-Movaghar A, Larney S. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet 2019;394:1560–79.
Desveaux L, Saragosa M, Kithulegoda N, Ivers NM. Family physician perceptions of their role in managing the opioid crisis. Ann Fam Med 2019;17:345–51.
Dowell D, Haegerich TM, Chou R. Centers for disease control and prevention guidelines for prescribing opioids for chronic pain—United States. MMWR Recomm Rep 2016;65:1–49.
Frank JW, Levy C, Matlock D, Calcaterra SL, Mueller SR, Koester S, Binswanger IA. Patients' perspectives on tapering of chronic opioid therapy: a qualitative study. Pain Med 2016;17:1838–47.
Hurstak EE, Kushel M, Chang J, Ceaser R, Zamora K, Miaskowski C, Knight K. The risks of opioid treatment: perspectives of primary care practitioners and patients from safety-net clinics. J Subst Abuse 2017;38:213–21.
Jones P, Seoane L, Kantrow C. Differences and similarities in the practice of medicine between Australia and the United States of America: challenges and opportunities for the university of queensland the ochsner clinical school. Ochsner J 2011;11:253–8.
Kahan DM. Choosing wisely Canada recommendations. Can Fam Physician 2018;64:368.
Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. “Those conversations in my experience don't go well”: a qualitative study of primary care provider experiences tapering long-term opioid medications. Pain Med 2018;19:2201–11.
Kirchner J, Smith JL, Powell BJ, Waltz TJ, Proctor EK. Getting a clinical innovation into practice: an introduction to implementation strategies. Psychiatry Res 2020; 283: 112467.
Langford A, Gnjidic D, Lin CW, Bero L, Penm J, Blyth F, Schneider F. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf 2020. doi: 10.1136/bmjqs-2020-010881.
doi: 10.1136/bmjqs-2020-010881
Matthias M, Johnson NL, Shields CG, Bair MJ, Mackie P, Huffman M, Alexander SC. “I'm not gonna pull the rug out from under you”: patient-provider communication about opioid tapering. J Pain 2017;18:1365–73.
Mathieson S, Maher CG, Ferreira GE, Hamilton M, Jansen J, McLachlan AJ, Underwood M, Lin CW. Deprescribing opioids in chronic non-cancer pain: systematic review of randomised trials. Drugs 2020;80:1563–76.
Mathieson S, Valenti L, Maher CG, Britt H, Li Q, Mclachlan AJ, Lin CW. Worsening trends in analgesics recommended for spinal pain in primary care. Eur Spine J 2018:27:1136–45.
McCrorie C, Closs J, House A, Petty D, Ziegler L, Glidewell L, West R, Foy R. Understanding long-term opioid prescribing for non-cancer pain in primary care: a qualitative study. BMC Fam Pract 2015;16:121.
Palagyi A, Keay L, Harper J, Potter JM, Lindley RI. Barricades and brickwalls—a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr 2016;16:15.
Penney LS, Ritenbaugh C, Debar LL, Elder C, Deyo RA. Provider and patient perspectives on opioids and alternative treatments for managing chronic pain: a qualitative study. BMC Fam Pract 2016;17:164.
Ritchie J, Lewis J, Nicholls CM, Ormston R. Qualitative research practice: a guide for social science students and researchers. England: Sage Open Med, 2014.
Ross J, Santhirapala R, MacEwen C, Coulter A. Helping patients choose wisely. BMJ 2018;361:k2585.
Royal Australian College of General Practitioners. Prescribing drugs of dependence in general practice, Part A—Clinical governance framework. Melbourne, Australia: The Royal Australian College of General Practitioners, 2015.
Royal College of Anaesthetists. Opioids Aware: a resource for patients and healthcare professionals to support prescribing of opioid medicines for pain, 2016. Available at: https://fpm.ac.uk/opioids-aware . Accessed July 30, 2020.
Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, Burroughs H, Jinks C. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant 2018;52:1893–907.
Scott IA, Hilmer SN, Reeve E, Potter K, Couteur DL, Rigby D, Gnjidic D, Del Mar CB, Roughead EE, Page A, Jansen J, Martin JH. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA 2015;175:82–834.
Skolnick P. The opioid epidemic, crisis and solutions. Annu Rev Pharmacol 2018;58:143–59.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349–57.
Toye F, Seers K, Tierney S, Barker KL. A qualitative evidence synthesis to explore healthcare professionals' experience of prescribing opioids to adults with chronic non-malignant pain. BMC Fam Pract 2017;18:94.
Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians' views on deprescribing in everyday practice. Ann Fam Med 2017;15:341–6.
White R, Hayes C, Boyes A, Chiu S, Paul CL. General practitioners and management of chronic noncancer pain: a cross-sectional survey of influences on opioid deprescribing. J Pain Res 2019;12:467–75.
Yu K, Anstey M, Cuthbertson J, Jammali-Blasi A, Melder A, Toleman J, Lindner R. Choosing Wisely in Australian hospitals: lessons from the field. Choosing Wisely Australia, 2019. Available at: https://insightplus.mja.com.au/2019/10/implementing-choosing-wisely-in-australian-hospitals-lessons-from-the-field/ . Accessed December 8, 2020.